GL1X · GenesisL1 explorer

Research workbench

The haddock structure model of GDP KRAS in complex with its allosteric inhibitor E22

Analyse The haddock structure model of GDP KRAS in complex with its allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6V5L
Type
protein
Length
169 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
GDP, QPD, MG
Pockets
1 · best druggability 0.45

Structure

solution nmr · 1 distinct chain · 38% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein16938% helix, 25% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • QPD · (2R)-2-[2-(1H-indole-3-carbonyl)hydrazinyl]-2-phenylacetamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11380.450.7725GDP

Compared structures

  • 6V5L · The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.